EUVIMEDEUVIMED entdecken
Crossref

Immunization status of patients with spinal muscular atrophy receiving nusinersen therapy

Mehmet Can Yeşilmen, Çağatay Günay, Gamze Sarıkaya Uzan, Özlem Özsoy, Semra Hız Kurul, Uluç Yiş

Archives de Pédiatrie · 2023

DOI: 10.1016/j.arcped.2023.03.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives de Pédiatrie, 2023. Verfasst von Mehmet Can Yeşilmen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey. Electronic address: mcanyesilmen@gmail.com. Hauptthemen laut MEDLINE: Influenza, Human, Muscular Atrophy, Spinal, Spinal Muscular Atrophies of Childhood, Influenza Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Children with chronic neurological diseases, including spinal muscular atrophy (SMA), are particularly susceptible to vaccine-preventable infections. We aimed to evaluate the age-appropriate immunization status and its relationship with nusinersen therapy in pediatric patients with SMA. METHODS: Children with SMA who received nusinersen treatment were included in this cross-sectional prospective study. Data were collected on SMA characteristics, nusinersen therapy, vaccination status according to the National Immunization Program (NIP), administration, and influenza vaccination recommendation. RESULTS: A total of 32 patients were enrolled. In patients with SMA type 1, the frequency of under-vaccination of hepatitis B, BCG, DTaP-IPV-HiB, OPV, and MMR was statistically higher than in patients with SMA type 2-3 (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanMuscular Atrophy, SpinalSpinal Muscular Atrophies of ChildhoodInfluenza VaccinesHumansChildProspective StudiesCross-Sectional StudiesBCG VaccineVaccinationPneumococcal VaccinesOligonucleotides

Stichwörter der Autor:innen

ImmunizationInfluenzaNusinersenSpinal muscular atrophyVaccination

Substanzen

BCG VaccineInfluenza VaccinesPneumococcal VaccinesnusinersenOligonucleotides

Autor:innen und Institutionen

  • Department of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey. Electronic address: mcanyesilmen@gmail.com.
  • Department of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.

Zitieren

APA

Yeşilmen, M. C., Günay, Ç., Sarıkaya Uzan, G., Özsoy, Ö., Hız Kurul, S., & Yiş, U. (2023). Immunization status of patients with spinal muscular atrophy receiving nusinersen therapy. Archives de Pédiatrie. https://doi.org/10.1016/j.arcped.2023.03.006

Vancouver

Yeşilmen MC, Günay Ç, Sarıkaya Uzan G, Özsoy Ö, Hız Kurul S, Yiş U. Immunization status of patients with spinal muscular atrophy receiving nusinersen therapy. Archives de Pédiatrie. 2023. doi:10.1016/j.arcped.2023.03.006

BibTeX
@article{Yeilmen2023,
  author = {Yeşilmen, Mehmet Can and Günay, Çağatay and Sarıkaya Uzan, Gamze and Özsoy, Özlem and Hız Kurul, Semra and Yiş, Uluç},
  title = {Immunization status of patients with spinal muscular atrophy receiving nusinersen therapy},
  journal = {Archives de Pédiatrie},
  year = {2023},
  doi = {10.1016/j.arcped.2023.03.006}
}
Kostenlos starten →